Chevron announces PMTCT partnership to combat mother-to-child transmission of HIV in Africa

NewsGuard 100/100 Score

Chevron announced today at the 2012 International AIDS Conference (AIDS 2012) a partnership initiative with Pact, the Business Leadership Council (BLC), mothers2mothers and the Global Fund to aggressively combat crisis-level mother-to-child transmission of HIV in Nigeria, Angola and South Africa.   

"We must intensify our collective efforts to meet the serious challenges to eliminating mother-to-child transmission of HIV head-on," said Rhonda Zygocki, Executive Vice President, Policy and Planning for Chevron. "We are mobilizing resources and strategic partners with specialized expertise to address critical issues facing Nigeria, Angola and South Africa in order to move toward an HIV-free generation by 2015."

The risk of mother-to-child transmission is an unfortunate reality in these countries. In Nigeria, approximately 75,000 babies are born with HIV each year, and most of these infections are due to transmission from their mothers. In South Africa, the country has the largest number of people living with HIV in the world, and approximately 30 percent of pregnant women were HIV-positive in 2009. Additionally in Angola, where more than 60 percent of the population is under 25 years old, an estimated 15 percent of the country's HIV cases are caused by mother-to-child transmission.

"As a company, we depend on a healthy society and healthy workforce," Zygocki said. "With HIV/AIDS disproportionately affecting women in Africa, it is critical that we come together in the fight against this disease. At Chevron, we recognize prevention of mother-to-child transmission (PMTCT) of HIV as both a critical intervention for the families of our employees and the communities where they work, as well as a realistic approach to the elimination of HIV entirely."

The PMTCT partnership areas of focus include:

  • Pact: Build the capacity of civil society organizations to increase PMTCT practices in Nigeria's Bayelsa State through education, raising awareness and reducing stigma.
  • BLC: Support the government of Nigeria to develop and implement models for accelerated PMTCT delivery over the next two years.
  • mothers2mothers: Lay the groundwork to establish its Mentor Mother model in Nigeria during the next 18 months.
  • The Global Fund: Advance PMTCT programs targeting Angola and South Africa.

This partnership is part of the $20 million commitment made by Chevron in June 2011 at the United Nations High Level Meeting on AIDS to support the global plan to eliminate new HIV infections among children by 2015 and keep their mothers alive.

"Nigeria is the front line in the fight to eliminate mother-to-child transmission of HIV, and its government is ready to dramatically scale up testing and treatment for mothers - through both public and private healthcare providers," said John Megrue, chairman of the Business Leadership Council for a Generation Born HIV Free (BLC). "Chevron is committed to improving public health in Nigeria and around the world, and I am grateful for its generous support to the BLC and to the Government of Nigeria. Together, we want to work with Nigeria's leaders to translate their vision for a generation born HIV free into reality."

"Every mother wants to protect her baby," said Mark Viso, president and CEO of Pact, an international NGO at work in 29 countries. "But if a mother with HIV never knows she is living with HIV, she can do little to prevent infecting her baby. In the Bayelsa state of Nigeria, where nearly 100,000 women become pregnant in any given year, an astounding 95,000 are never tested for HIV. That has to change, and Chevron is helping make that change possible." To hear more from Mark Viso about this partnership, please click here.

"Every mother living with HIV should have access to the support and care she needs to defend her health and protect her baby from HIV infection," added Robin Smalley, co-founder of mothers2mothers. "We are thrilled to partner with Chevron to expand the reach of our Mentor Mother model and champion the health and well-being of Nigeria's mothers and children."

"The private sector is an extremely important partner in the fight against the disease, both in program implementation and as a supportive donor," said Gabriel Jaramillo, general manager of the Global Fund. "Chevron became the first Corporate Champion in 2008 and recommitted additional resources in 2010. We are hugely encouraged by its continued support for the Global Fund and we hope that other private sector companies will follow Chevron's example."

Source: Chevron

Comments

  1. Yetimwork Tekle Yetimwork Tekle Ethiopia says:

    I think instituting  Mother to mother support group in the health facility   is quite essential strategy and defiantly contribute a lot  to HIV free child survival in the near future.
    Because, MSG (mother support group) or mother to mother  approach:
    1.lessens HIV-related stigma and discrimination,
    2.increase HIV-positive mothers’ understanding of infant feeding options, breast care and attachment (Tertiary prevention)
    3.Reduce the incidence of new sexually transmitted infections and HIV among girls and women  ( they can teach in the health facility and in the community  for primary prevention purpose  )
    Increase acceptance and use of family planning among all postpartum women and including all HIV positive mothers  ( for secondary prevention )
    Help to build  strong linkages with other ART....programs and services that strengthen women’s health
    helps to improve decision making (e.g., nutritional support, condom utilization, income-generating activities and skills training).
    Improve counseling
    The trained mothers mentors as expert patient trainers (EPTs )  can also contributes a lot to improve the quality of the comprehensive PMTCT/MNCH training while they are introduced in skill station

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication